Case Study: Phase III clinical trial in the United States | 2022
Client A biopharmaceutical company sponsoring a Phase III clinical trial in the United States. Challenge The trial required the recruitment of patients with a neurological pain indication. The sponsor perceived a potential concern that patients had several alternative treatment options, including commercially available products, and therefore, may not be interested in a clinical study opportunity…